SWEDESBORO, NEW JERSEY (1.28.22) – Last Thursday, North America’s largest pure-play distributor serving science, Thomas Scientific, announced a comprehensive Marketing and Distribution Agreement with Maxim Biomedical (MaximBio), a leading diagnostic healthcare company and manufacturer of trusted diagnostic solutions. The Agreement is specific to MaximBio's ClearDetectTM COVID-19 Antigen Home Test (ClearDetectTM), which received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration on January 19, 2022.
The ClearDetectTM COVID-19 Antigen Home Test employs proven Lateral Flow Assay (LFA) technology with a simplified workflow that can easily be done at home without the need for equipment or a reader. The test's unique format involves only 3 components – a swab, a test strip, and a test tube pre-filled with sample buffer. This eliminates reagent measuring or the need to handle dropper bottles as required with other card-based and self-test systems.
“For over a century, Thomas Scientific has been committed to offering quality laboratory products while catering to the unique needs of the individual customer,” said Michael Brown, Senior VP, Clinical Diagnostics at Thomas Scientific. “We are excited to add MaximBio's innovative test to our product offering.”
When compared to an EUA authorized PCR method, the MaximBio ClearDetectTM COVID-19 Antigen Home Test performed well, achieving 86.9% Positive Agreement (PPA) and 98.9% Negative Agreement (NPA), making it one of the more sensitive and specific antigen tests available. The test also performed admirably when evaluated by the NIH with specimens positive for the Omicron variant, detecting 100% of live virus Omicron samples diluted to a PCR Ct value of 25.8. In the same study the assay detected the Omicron variant at a higher dilution than two other EUA-approved antigen tests.
.jpg)
The test will be available in two kit configurations – packaged two (2) tests in a box for convenient at-home use, and in a bulk 25-test pack amenable for healthcare settings, schools, workplaces, and other high-volume testing scenarios. Thomas Scientific will market both configurations and plans to price them competitively. MaximBio is currently ramping up production to meet the demand for COVID-19 testing and Thomas Scientific's desire to fulfil customer needs.
When asked about the collaboration, Anthony Morrison, MaximBio's Chief Commercial Officer, affirmed, "Thomas Scientific’s dedication to provide the best products with personal, efficient service makes them an ideal partner for MaximBio as we team up to help meet the growing demand for COVID-19 testing.”
Thomas Scientific’s Clinical Diagnostics team has been instrumental in serving the testing needs of organizations large and small throughout the COVID-19 pandemic. In December 2020, they were awarded a $106M contract by the Defense Logistics Agency to supply nasopharyngeal swabs to five federal executive departments.
Those interested in purchasing the ClearDetectTM COVID-19 Antigen Home Test can view the product listing online here or call 833.544.7447 to be connected with a local Thomas Scientific sales representative.
About Thomas Scientific
Founded in 1900, Thomas Scientific provides the latest in supplies, equipment, and supply chain solutions to the scientific community – supporting all laboratory research, biopharmaceutical, medical device, clinical diagnostics, cleanroom, and other related end markets. In accordance with our mission to be the most trusted partner in science for our customers, suppliers, and associates, we deliver individualized service and a comprehensive product portfolio at competitive prices, combined with customized supply chain service solutions. Whether you work in a laboratory or controlled environment setting, or perform your testing in the field, Thomas Scientific has the products you need. For more information, visit thomassci.com.
About Maxim Biomedical Inc.
Headquartered in Rockville, MD, Maxim Biomedical is a leading diagnostic healthcare company providing innovative solutions through the development and manufacture of trusted testing solutions. Our mission is to create diagnostic products that are affordable, accessible, and enable actionable testing to improve patient outcomes around the globe. For more information, visit maximbio.com.
Media Contact
Diane Skala, Vice President, Corporate and Supplier Marketing Services
856.832.3296
diane.skala@thomassci.com